Study investigators sought to determine a possible genetic mechanism for a cerebral small vessel disease and its link to stroke, tremor, and cognitive impairment.
This study evaluated the association between prior oral anticoagulant use and in-hospital outcomes among patients with nontraumatic intracerebral hemorrhage.
Survivors of primary ICH have significant differences in subtypes and severity of CSVD, which has implications for ICH risk.
Electric motorized scooter (eScooter)-related injuries, including intracranial hemorrhage and fractures requiring operative intervention, have increased over time and are frequently associated with alcohol and illicit substance use.
Low-dose aspirin use for primary prevention of cardiovascular events in people without symptomatic cardiovascular disease was associated with an increased risk for intracranial hemorrhage.
For patients with intracerebral hemorrhage, those who start antiplatelet therapy do not have an increased risk for recurrence, including those with cerebral microbleeds.
Investigators sought to determine the risk for intracerebral hemorrhage in pregnancy and during the postpartum period.
The MISTIE procedure plus rtPA was associated with significantly decreased ICH volumes compared with the medical group.
The avoidance of SBP <120 mm Hg in individuals with acute ICH may help prevent cerebral ischemia and neurologic deterioration.
Models using 4 or 5 predictors have acceptable to good discrimination for determining additional intracerebral hemorrhage growth in patients with acute intracerebral hemorrhage.
